These results confirmed our earlier observation in a study performed in ovariectomized rats with developing osteopenia, where 8-wk i.p. administration of nesfatin-1 mitigated adverse changes in DXA parameters of tibia and femur [42]. This evidence concerns the gene NUCB2 and Osteopenia.